Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities

There is growing evidence for the use of pharmacogenomics in psychotropic prescribing. People with intellectual disabilities are disproportionately prescribed psychotropics and are at risk of polypharmacy. There is an urgent need for safeguards to prevent psychotropic overprescribing but it is equal...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Bhathika, Steward, Charles, Courtenay, Ken, Andrews, Timothy, Shankar, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438475/
https://www.ncbi.nlm.nih.gov/pubmed/35975635
http://dx.doi.org/10.1192/bjo.2022.554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438475/
https://www.ncbi.nlm.nih.gov/pubmed/35975635
http://dx.doi.org/10.1192/bjo.2022.554

Ejemplares similares